909 related articles for article (PubMed ID: 22634756)
21. The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients.
Jiang Z; Jhunjhunwala S; Liu J; Haverty PM; Kennemer MI; Guan Y; Lee W; Carnevali P; Stinson J; Johnson S; Diao J; Yeung S; Jubb A; Ye W; Wu TD; Kapadia SB; de Sauvage FJ; Gentleman RC; Stern HM; Seshagiri S; Pant KP; Modrusan Z; Ballinger DG; Zhang Z
Genome Res; 2012 Apr; 22(4):593-601. PubMed ID: 22267523
[TBL] [Abstract][Full Text] [Related]
22. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
23. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
24. NGS-based profiling reveals a critical contributing role of somatic D-loop mtDNA mutations in HBV-related hepatocarcinogenesis.
Yin C; Li DY; Guo X; Cao HY; Chen YB; Zhou F; Ge NJ; Liu Y; Guo SS; Zhao Z; Yang HS; Xing JL
Ann Oncol; 2019 Jun; 30(6):953-962. PubMed ID: 30887045
[TBL] [Abstract][Full Text] [Related]
25. Diverse modes of genomic alteration in hepatocellular carcinoma.
Jhunjhunwala S; Jiang Z; Stawiski EW; Gnad F; Liu J; Mayba O; Du P; Diao J; Johnson S; Wong KF; Gao Z; Li Y; Wu TD; Kapadia SB; Modrusan Z; French DM; Luk JM; Seshagiri S; Zhang Z
Genome Biol; 2014 Aug; 15(8):436. PubMed ID: 25159915
[TBL] [Abstract][Full Text] [Related]
26. Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma.
Kan Z; Zheng H; Liu X; Li S; Barber TD; Gong Z; Gao H; Hao K; Willard MD; Xu J; Hauptschein R; Rejto PA; Fernandez J; Wang G; Zhang Q; Wang B; Chen R; Wang J; Lee NP; Zhou W; Lin Z; Peng Z; Yi K; Chen S; Li L; Fan X; Yang J; Ye R; Ju J; Wang K; Estrella H; Deng S; Wei P; Qiu M; Wulur IH; Liu J; Ehsani ME; Zhang C; Loboda A; Sung WK; Aggarwal A; Poon RT; Fan ST; Wang J; Hardwick J; Reinhard C; Dai H; Li Y; Luk JM; Mao M
Genome Res; 2013 Sep; 23(9):1422-33. PubMed ID: 23788652
[TBL] [Abstract][Full Text] [Related]
27. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma.
Li M; Zhao H; Zhang X; Wood LD; Anders RA; Choti MA; Pawlik TM; Daniel HD; Kannangai R; Offerhaus GJ; Velculescu VE; Wang L; Zhou S; Vogelstein B; Hruban RH; Papadopoulos N; Cai J; Torbenson MS; Kinzler KW
Nat Genet; 2011 Aug; 43(9):828-9. PubMed ID: 21822264
[TBL] [Abstract][Full Text] [Related]
28. Molecular aspects of hepatic carcinogenesis.
Nita ME; Alves VA; Carrilho FJ; Ono-Nita SK; Mello ES; Gama-Rodrigues JJ
Rev Inst Med Trop Sao Paulo; 2002; 44(1):39-48. PubMed ID: 11896411
[TBL] [Abstract][Full Text] [Related]
29. HBV genome integration and genetic instability in HBsAg-negative and anti-HCV-positive hepatocellular carcinoma in Japan.
Matsuzaki Y; Chiba T; Hadama T; Asaoka H; Doy M; Shoda J; Tanaka N; Kinoshita M
Cancer Lett; 1997 Oct; 119(1):53-61. PubMed ID: 18372522
[TBL] [Abstract][Full Text] [Related]
30. Suppression of PROX1-mediated TERT expression in hepatitis B viral hepatocellular carcinoma.
Kim YJ; Yoo JE; Jeon Y; Chong JU; Choi GH; Song DG; Jung SH; Oh BK; Park YN
Int J Cancer; 2018 Dec; 143(12):3155-3168. PubMed ID: 29987895
[TBL] [Abstract][Full Text] [Related]
31. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.
Yoo S; Wang W; Wang Q; Fiel MI; Lee E; Hiotis SP; Zhu J
BMC Med; 2017 Dec; 15(1):214. PubMed ID: 29212479
[TBL] [Abstract][Full Text] [Related]
32. Gene copy number variations in the leukocyte genome of hepatocellular carcinoma patients with integrated hepatitis B virus DNA.
Pang Y; Guo W; Wang J; Xu G; Cheng K; Cao G; Wu M; Cheng S; Liu S
Oncotarget; 2016 Feb; 7(7):8006-18. PubMed ID: 26769853
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression.
Okabe H; Satoh S; Kato T; Kitahara O; Yanagawa R; Yamaoka Y; Tsunoda T; Furukawa Y; Nakamura Y
Cancer Res; 2001 Mar; 61(5):2129-37. PubMed ID: 11280777
[TBL] [Abstract][Full Text] [Related]
34. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
35. Integration of hepatitis B virus containing mutations in the core promoter/X gene in patients with hepatocellular carcinoma.
Momosaki S; Hsia CC; Nakashima Y; Kojiro M; Tabor E
Dig Liver Dis; 2003 Nov; 35(11):795-800. PubMed ID: 14674670
[TBL] [Abstract][Full Text] [Related]
36. Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma.
Yeh SH; Chiu CM; Chen CL; Lu SF; Hsu HC; Chen DS; Chen PJ
Int J Cancer; 2007 Apr; 120(8):1610-7. PubMed ID: 17230529
[TBL] [Abstract][Full Text] [Related]
37. Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.
Tornesello ML; Buonaguro L; Izzo F; Buonaguro FM
Oncotarget; 2016 May; 7(18):25087-102. PubMed ID: 26943571
[TBL] [Abstract][Full Text] [Related]
38. Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity.
Fujimoto A; Furuta M; Shiraishi Y; Gotoh K; Kawakami Y; Arihiro K; Nakamura T; Ueno M; Ariizumi S; Nguyen HH; Shigemizu D; Abe T; Boroevich KA; Nakano K; Sasaki A; Kitada R; Maejima K; Yamamoto Y; Tanaka H; Shibuya T; Shibata T; Ojima H; Shimada K; Hayami S; Shigekawa Y; Aikata H; Ohdan H; Marubashi S; Yamada T; Kubo M; Hirano S; Ishikawa O; Yamamoto M; Yamaue H; Chayama K; Miyano S; Tsunoda T; Nakagawa H
Nat Commun; 2015 Jan; 6():6120. PubMed ID: 25636086
[TBL] [Abstract][Full Text] [Related]
39. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.
Xue R; Li R; Guo H; Guo L; Su Z; Ni X; Qi L; Zhang T; Li Q; Zhang Z; Xie XS; Bai F; Zhang N
Gastroenterology; 2016 Apr; 150(4):998-1008. PubMed ID: 26752112
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of genetic aberrations linked to tumorigenesis in regenerative nodules of liver cirrhosis.
Kim SK; Takeda H; Takai A; Matsumoto T; Kakiuchi N; Yokoyama A; Yoshida K; Kaido T; Uemoto S; Minamiguchi S; Haga H; Shiraishi Y; Miyano S; Seno H; Ogawa S; Marusawa H
J Gastroenterol; 2019 Jul; 54(7):628-640. PubMed ID: 30756187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
